In this article we will take a look at whether hedge funds think Enanta Pharmaceuticals Inc (NASDAQ:ENTA) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get tips from investment bankers and industry insiders. Sure they sometimes fail miserably, but their consensus stock picks historically outperformed the market after adjusting for known risk factors. Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) the right pick for your portfolio? Prominent investors are in a pessimistic mood.